NORMAN, OKLA. – The University of Oklahoma announced today the students named to its spring 2025 honor roll, a distinction given to those who achieve the highest academic standards.
A total of 10,801 students were named to the spring 2025 honor roll. Of these students, 4,564 were named to the President’s Honor Roll for earning an “A” grade in all their courses.
The honor roll recognizes undergraduate students at OU’s Norman campus and OU Health Sciences. Most colleges include full-time students who completed at least 12 letter-graded credit hours. Those with a 4.0 grade-point average were named to the President’s Honor Roll. Students with a grade-point average of 3.5 or higher are named to the Dean’s Honor Roll. In the Gallogly College of Engineering and the Mewbourne College of Earth and Energy, students with a grade-point average of 3.0 or higher qualify for recognition.
A searchable honor roll list for spring 2025 is available for download online. Students who are on both the President’s Honor Roll and Dean’s Honor Roll are denoted by an asterisk.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.
The University of Oklahoma Honors College hosted its 38th annual Undergraduate Research Day on April 16 in the Thurman J. White Forum Building. Over 300 people attended, and 175 students presented their posters and projects to visitors, faculty members, judges and peers.
The Collaborative Doctor of Education (Ed.D.) in Educational Leadership offers emerging leaders across Oklahoma’s PK–12 public education system a doctoral experience designed to be as relevant as it is rigorous.
A study published today in PLOS Medicine has identified two new genetic pathways that contribute to cardiometabolic disease, which includes heart disease, obesity and diabetes. The research, led by Dharambir Sanghera, Ph.D., of the University of Oklahoma, represents a step toward targeting the diseases more precisely.